Skip to main content
. 2025 Sep 18;12:1629369. doi: 10.3389/fmed.2025.1629369

Table 1.

Overview of basic data of the included studies.

Author year Country Study design Participants Interventional procedure type Data source Main outcome Total Cases/Sample size (%)
Stefano (26) Italy Prospective cohort study STEMI Primary PCI Policlinico San Matteo in Pavia, Italy, and Centro Cardiologico
Monzino in Milan, Italy
CI-AKI 3,736 229/3736 (6.13%)
Yinghua (19) China Retrospective study ACS PCI Affiliated Hospital of Xuzhou Medical University and the East Hospital of Xuzhou Medical University CI-AKI 939 D:69/722
Benjamin (23) America Retrospective cohort study STEMI Primary PCI UT Methodist Hospital AKI 840 /
Yuhei (27) Japan Retrospective observational study STEMI Primary PCI Miyazaki Medical Association
Hospital
AKI 908 77/908 (8.48%)
Akaphol (24) Thailand Retrospective cohort STEMI Primary PCI Central Chest Institute of Thailand,a tertiary care hospital AKI 1,617 195/1617 (12.06%)
Pei-Chun (30) China Retrospective data ACS PCI Taiwan National Health Insurance Research Database AKI 82,186 3829/82186 (4.66%)
Amir (33) Iran Retrospective study ACS PCI Tehran Heart Center AKIN 4,592 646/4592 (14.07%)
Hang (20) China Retrospective analysis STEMI Emergency PCI Xuzhou Medical University Hospital CI-AKI 542 74/542 (13.65%)
Faysal (28) Turkey Retrospective study STEMI Primary PCI Van Training and Research hospital CIN 2,289 219/2289 (9.57%)
Kai (21) China Retrospective study NSTE-ACS PCI The Affiliated Hospital of Xuzhou Medical University CI-AKI 1,156 168/1156 (14.53%)
Yue (22) China Retrospective study ACS PCI Atherosclerotic cardiovascular disease (ASCVD) database-Affiliated Hospital of Xuzhou Medical University CI-AKI 1,073 213/1073 (19.85%)
Sukrisd (25) Thailand Retrospective cohort STEMI Primary PCI Central Chest Institute of Thailand (CCIT) CIN 217 43/217 (19.82%)
Kai-yang (32) China Prospective observational study STEMI/NSTE-ACS Emergent PCI Guangdong general hospital CIN 692 55/692 (7.95%)
Hui (29) China Retrospective analysis STEMI Primary CAG/PCI D: the First Affiliated Hospital of Xinxiang Medical College; V: the First Affiliated Hospital of Henan
Polytechnic University
AKI 452 D:57/364
Ling (31) China Retrospective cohort study AMI CAG/PCI Changzhou No.2 People’s Hospital of Nanjing Medical University CI-AKI 1,495 226/1495 (15.12%)
Xuejun (18) China Retrospective study AMI CAG/PCI D: central branch of The Affiliated Changzhou No.2 people’s Hospital of Nanjing Medical University; V: Yanghu branch of hospital CI-AKI 920 164/920 (17.83%)

STEMI, ST-elevation myocardial infarction; pPCI, primary Percutaneous Coronary Interventions; ACS, acute coronary syndromes; CAG, coronary angiography; PCI, percutaneous coronary intervention; AMI, acute myocardial infarction; T2DM, type 2 diabetes mellitus; NSTE-ACS, non-ST-elevation acute coronary syndrome, DM, diabetes mellitus; D, derivation; V, validation; CI-AKI, contrast-induced acute kidney injury; AKI, acute kidney injury; AKIN, acute kidney injury necrosis; CIN, contrast-induced nephropathy; SCr, serum creatinine.